This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers may develop nanodrugs due to their smaller surface area to allows drugs to dissolve faster, or nanoparticles may encapsulate drugs, so they last longer in the body. Since then, the drug has been used off-label in breast cancer and other types of cancer. He says, “It gave a new lease [on] life to the field”.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
A team of scientists from the universities of Glasgow and Tel Aviv has developed a groundbreaking method to transform the brain parasite Toxoplasma gondii into a potential vehicle for delivering therapeutic treatments directly to brain cells.
DrugDelivery Devices Symposium. We have the distinct privilege of unveiling Oxford Global’s DrugDelivery Devices Symposium, taking place on the 10th of March, 2021. Discuss Combination Product Development & Engineering with leading experts such as Andrew Yum , United Therapeutics and Ning Yu , Biogen.
Four faculty members in the University of Arizona College of Engineering have received CAREER Awards from the National Science Foundation. Their work ranges from improving drugdelivery for disease and managing renewable energy to advancing quantum technology.
SMi presents the Inaugural: Transdermal and Microneedle DrugDelivery Conference. Latest innovations in drugdelivery beyond the needle. SMi is proud to present the Transdermal and Microneedle DrugDelivery Conference, taking place on the 24th to 25th January 2022, in London. pharmaphorum . pharmaphorum .
Innovations in Formulation and Device Design for Enhanced Subcutaneous Delivery. As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. Device Engineering. Human Factors.
Texas A&M associate professor Akhilesh Gaharwar and graduate student Patrick Lee are developing a new class of hydrogels that can leverage light for drugdelivery and regenerative medicine treatments. Credit: Texas A&M Engineering Hydrogels are commonly used inside the body to help in tissue regeneration and drugdelivery.
Cytonus Therapeutics Announces Publication in Nature Biomedical Engineering of Preclinical Results to Support Disease-Specific Drug-Delivery Capabilities of their Novel Cargocyte™ Platform Cytonus Therapeutics Announces Publication in Nature Biomedical Engineering of Preclinical Results to Support Disease-Specific Drug-Delivery Capabilities (..)
The 2023 Transdermal and Microneedle DrugDelivery Conference will explore real world applications of microneedles in drugdelivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization.
Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility.
Nanoscale machinery has many uses, including drugdelivery, single-atom transistor technology, or memory storage. Credit: Credit: University of Warwick Nanoscale machinery has many uses, including drugdelivery, single-atom transistor technology, or memory storage.
Dill/NIST In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers.
Owing to their unique size and physicochemical properties ( surface roughness, surface area, surface energy, crystal structure and shape ), nanoparticles can be widely used as a contrasting agent in medical imaging, a vesicle to cross the blood-brain barrier and a carrier for targeted delivery of genes / drugs, proteins, vaccines and antibiotics.
Connected DrugDelivery Devices. Hear about new technological advances in the delivery of large volume drugs. Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives. Primary Packaging Development.
Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable.
SMi Group’s 14 th Annual Conference and Exhibition: Pre-Filled Syringes and Injectable Drug Devices 2022 – 12 th – 13 th January 2022. Sustainability for Drug Devices Focus Day – 14 th January 2022. The Future of DrugDelivery and Combination Product Device Design. Louise Place, Director, Devices, GSK.
The 3 rd Annual Blood-Brain Barrier Summit is dedicated to helping drug developers enhance drugdelivery across the Blood-Brain Barrier (BBB) to enable effective treatments for neurodegenerative diseases. DOWNLOAD THE PROGRAM HERE. New for this year we also explore the mechanisms of SARS-CoV-2 brain entry.
As part of SMi’s leading series of drugdelivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives. Uncover the key considerations to ensure optimal lifecycle management for drugdelivery devices.
Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. The engineered cells reduced inflammation and prevented a type of damage to bone, known as bone erosion, in a mouse model of rheumatoid arthritis. million adults in the United States.
Scientists have established a new method to image proteins that could lead to new discoveries in disease through biological tissue and cell analysis and the development of new biomaterials that can be used for the next generation of drugdelivery systems and medical devices.
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. As part of SAE Media Group’s leading injectable drugdelivery portfolio, this event is not to be missed.
The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drugdelivery. The industry is now poised to exploit the full therapeutic potential of these vehicles for emerging payloads and extrahepatic delivery.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. Consequently, pharmaceutical and biotech companies are increasingly looking to provide devices that allow patients to self-administer drugs. It just felt right.
Paul Roussel is currently a Senior Director of Combination Products at Kiniksa Pharmaceuticals in the CMC Technical Operations Group with over 20 years of experience in the drugdelivery and medical device space. in Plastics Engineering and M.S. in Manufacturing Engineering. He completed his B.S.
An international team led by a Skoltech researcher has developed a method of fabrication for biodegradable polymer microcapsules, made more efficient by turning to an unusual source of inspiration – traditional Russian dumpling, or pelmeni, making. The two papers were published in Materials and Design and ACS Applied Materials and Interfaces.
SAE Media Group reports: Mitchell de Long, Vice President, Chemistry from Aerie Pharmaceuticals and Naj Sharif, Vice President, Ophthalmology Innovation Center from Santen Inc USA cordially invite industry experts to speak at the 5th Annual Ophthalmic Drugs Conference. Ophthalmic Drugs. This event is less than four weeks away.
This Hanson Wade event is aimed at experts looking to deliver CNS drug candidates safely and successfully across the blood-brain barrier (BBB). Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers.
The Latest Innovations In Digital Health And On-Body DrugDelivery For The Pharmaceutical Industry. Discover advances in device design and development for large volume delivery via on-body injectors. Explore the key drivers of novel drug products for the development for on-body injectors. Device Engineering.
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drugdelivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.
Known as “two-dimensional electrolytes”, these smart materials could potentially be used in many things from drugdelivery to energy storage Credit: National University of Singapore Intelligent materials, the latest revolution in the field of materials science, can adapt their properties depending on changes in their surroundings.
In order to promote the use of exosomes in various therapeutic applications including targeted drugdelivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Our Social Media Platform.
– Before the huge potential of tiny nanocarriers for highly targeted drugdelivery and environmental clean-up can be realized, scientists first need to be able to see them. Credit: Washington State University PULLMAN, Wash.
Newly-published “contact lens technologies of the future” paper reviews innovative uses for disease detection and therapy, drugdelivery, vision enhancement and mor Credit: Centre for Ocular Research & Education (CORE) WATERLOO, Ontario, March 29, 2021–A newly-published paper represents one of the most comprehensive reviews of (..)
As part of SMi’s leading injectable series, the 2022 conference will provide an exclusive insight into the latest developing technologies for device design, advances in parenteral device platforms and development, insights into growing integration of digital health and deep dives into recent case studies on novel delivery systems.
The new master agreement, covering another five years, will foster research on genetic medicines, intrathecal delivery of therapeutics into the spinal canal or subarachnoid space of the brain, and the use of nanoparticles to improve drugdelivery.
Top of the list is the Verily Value Suite analytics platform – designed to help health systems deliver personalised patient care – and various early-stage programmes, including “remote patient monitoring for heart failure and micro needles for drugdelivery.”
For instance, drugdelivery devices may meet all technical requirements regarding dosage and delivery methods but fail in practical use by patients. This involves guiding through steps like design thinking, behavioral design, human factors and engineering, to make sure the process produces reliable, patient-informed evidence.
Further, since 2020, the Food and Drug Administration (FDA) has approved 125 medical devices. Other desirable attributes provided by the medical device coating include, reactivity to different stimuli, drugdelivery / eluting capabilities, and anti-fouling traits.
At Gilead he led the organization in the successful filing of numerous New Drug Applications (NDAs) and supplemental label updates across multiple therapeutic areas. Prior to this, he spent nine years at Gilead Sciences, where most recently he was Chief Scientific Officer and Head of Research & Development.
With the help of genetic engineering, synthetic mRNAs can express proteins, as they structurally resemble a natural mRNA. The production of such drug products requires skilled labor, stringent manufacturing protocols and specialized expertise.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content